Global X Financial Statements From 2010 to 2025
| GNOM Etf | USD 10.13 0.16 1.60% |
Check Global X financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Global X's main balance sheet or income statement drivers, such as , as well as many indicators such as . Global financial statements analysis is a perfect complement when working with Global X Valuation or Volatility modules.
Global |
Global X Genomics ETF Price To Sales Analysis
Global X's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Global X Price To Sales | 4.82 X |
Most of Global X's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Global X Genomics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Global X Genomics has a Price To Sales of 4.82 times. This is much higher than that of the Global X Funds family and significantly higher than that of the Health category. The price to sales for all United States etfs is notably lower than that of the firm.
Global X Genomics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Global X's current stock value. Our valuation model uses many indicators to compare Global X value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Global X competition to find correlations between indicators driving Global X's intrinsic value. More Info.Global X Genomics is one of the top ETFs in price to earning as compared to similar ETFs. It also is one of the top ETFs in price to book as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value Global X by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Global X Financial Statements
Global X investors utilize fundamental indicators, such as revenue or net income, to predict how Global Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The fund invests at least 80 percent of its total assets in the securities of the underlying index. Gx Genomics is traded on NASDAQ Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Global X Correlation against competitors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
The market value of Global X Genomics is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global X's value that differs from its market value or its book value, called intrinsic value, which is Global X's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global X's market value can be influenced by many factors that don't directly affect Global X's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global X's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global X is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global X's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.